The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of neoadjuvant FLOT and chemoradiation for trimodality therapy of esophageal/GEJ adenocarcinoma.
 
Jeffrey Olsen
Honoraria - American Society of Therapeutic Radiation Oncology; SYNTACTX
 
Alexis Leal
Employment - Elsevier
Leadership - Elsevier
Honoraria - MedPro Specialty Advisory Board
Research Funding - Abbvie (Inst); Antengene (Inst); Arrys Therapeutics (Inst); Bristol-Myers Squibb (Inst); Conjupro Biotherapeutics (Inst); Corcept Therapeutics (Inst); Elicio Therapeutics (Inst); Exelixis (Inst); FameWave Ltd. (Inst); Hutchison MediPharma (Inst); Takeda (Inst)
 
Sunnie Kim
Honoraria - Merck
Consulting or Advisory Role - Astellas Pharma; Daiichi Sankyo/Lilly; I-Mab
Research Funding - Merck
 
Karyn Goodman
Consulting or Advisory Role - Novartis; Philips Healthcare; RenovoRx; Roche/Genentech
Other Relationship - National Cancer Institute
 
David Binder
No Relationships to Disclose
 
Matthew Blum
No Relationships to Disclose
 
Crystal Erickson
No Relationships to Disclose
 
Robert Hoyer
No Relationships to Disclose
 
Douglas Kemme
No Relationships to Disclose
 
Christopher Lieu
Consulting or Advisory Role - Amgen (Inst)
Research Funding - Genentech (Inst)
 
Arthur Liu
No Relationships to Disclose
 
Megan Marsh
No Relationships to Disclose
 
Lynn Mathew
No Relationships to Disclose
 
Martin McCarter
Consulting or Advisory Role - Merck
Research Funding - Merck; Taiho Oncology
Patents, Royalties, Other Intellectual Property - University of Colorado
 
Wells Messersmith
Honoraria - Research to Practice (Inst)
Consulting or Advisory Role - Amgen; Criterium (Inst)
Research Funding - Agenus (Inst); ALX Oncology (Inst); AstraZeneca/MedImmune (I); Beigene (Inst); CanBas (Inst); Exelixis (Inst); Experimental Drug Development Centre (EDDC); FATE Therapeutics (Inst); Mirati Therapeutics (Inst); Nurix (Inst); Pfizer (Inst); PureTech (Inst); RasCal (Inst); Revolution Medicines (Inst)
 
Joshua Petit
No Relationships to Disclose
 
Daniel Shonebarger
No Relationships to Disclose
 
Timothy Waxweiler
Employment - Medtronic (I)
Stock and Other Ownership Interests - Medtronic (I)